Trademark Overview
On Tuesday, October 15, 2024, a trademark application was filed for ZIPBIO with the United States Patent and Trademark Office. The USPTO has given the ZIPBIO trademark a serial number of 98801864. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, October 15, 2024. This trademark is owned by Zip Bio Inc.. The ZIPBIO trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
pharmaceutical preparations for the treatment of ophthalmological diseases and disorders; therapeutic proteins for medical for the treatment of ophthalmological diseases and disorders; biologics for medical use, namely, biological preparation for the treatment of ophthalmological diseases and disorders; pharmaceutical preparations, biological preparations, biological therapies, clinical medical reagents and therapeutic proteins for use in the treatment of genetic-based and cell-based diseases and disorders; pharmaceutical preparations, biological preparations, biological therapies, clinical medical reagents and therapeutic proteins for use in gene therapy, cell therapy, gene diagnosis, cell diagnosis, gene testing and cell testing; pharmaceutical preparations, biological preparations, biological therapies, clinical medical reagents and therapeutic proteins for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflamma...
research and development relating to pharmaceuticals for the treatment of ophthalmological diseases and disorders; scientific research and development in connection with protein therapies for use in pharmaceutical products; medical research and product development in the fields of biotechnology, drug discovery, pharmaceuticals, scientific research, biological preparations and protein therapeutics; research and development relating to pharmaceutical preparations, biological preparations and therapeutic proteins for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; research and development in the field of gene therapy, gene diagnosis and gene testing; biological research; chemical research; conducting clinical trials for others; scientific research; scientific laboratory s...
